EMAGEON, INC.
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q
|
|
|
þ |
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the quarterly period ended September 30, 2006
|
|
|
o |
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
For the transition period from to
Commission file number 0-51149
EMAGEON INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
63-1240138 |
|
|
|
(State or other jurisdiction of incorporation or
organization)
|
|
(I.R.S. Employer Identification No.) |
|
|
|
1200 Corporate Drive, Suite 200 |
|
|
Birmingham, Alabama
|
|
35242 |
|
|
|
(Address of principal executive offices)
|
|
(Zip Code) |
(205) 980-9222
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed
by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or
for such shorter period that the registrant was required to file such reports), and (2) has been
subject to such filing requirements for the past 90 days.
þ Yes o No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated
filer, or a non-accelerated filer. See definition of accelerated filer and large accelerated
filer in Rule 12b-2 of the Exchange Act.
Large Accelerated Filer
o Accelerated
Filer þ
Non-Accelerated Filer o
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of
the Exchange Act).
o Yes þ No
Common
stock, par value $0.001 per share: 21,174,339 shares outstanding as of October 31,
2006.
Form 10-Q
September 30, 2006
Table of Contents
PART I. FINANCIAL INFORMATION
ITEM
1. CONDENSED FINANCIAL STATEMENTS
EMAGEON INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
September 30, |
|
|
December 31, |
|
|
|
2006 |
|
|
2005 |
|
|
|
(Unaudited) |
|
|
|
|
|
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
13,762 |
|
|
$ |
15,520 |
|
Marketable securities |
|
|
|
|
|
|
4,951 |
|
Trade accounts receivable, net |
|
|
29,959 |
|
|
|
29,261 |
|
Inventories |
|
|
9,875 |
|
|
|
8,031 |
|
Prepaid expenses and other current assets |
|
|
3,774 |
|
|
|
3,052 |
|
|
|
|
|
|
|
|
Total current assets |
|
|
57,370 |
|
|
|
60,815 |
|
Property and equipment, net |
|
|
19,507 |
|
|
|
21,433 |
|
Other noncurrent assets |
|
|
1,647 |
|
|
|
1,419 |
|
Intangible assets, net |
|
|
31,427 |
|
|
|
34,277 |
|
|
|
|
|
|
|
|
Total assets |
|
$ |
109,951 |
|
|
$ |
117,944 |
|
|
|
|
|
|
|
|
LIABILITIES AND STOCKHOLDERS EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
9,285 |
|
|
$ |
13,196 |
|
Accrued payroll and related costs |
|
|
3,447 |
|
|
|
4,104 |
|
Deferred revenue |
|
|
26,649 |
|
|
|
26,057 |
|
Other accrued expenses |
|
|
3,634 |
|
|
|
3,978 |
|
Current portion of long-term debt and capital lease obligations |
|
|
1,639 |
|
|
|
2,763 |
|
|
|
|
|
|
|
|
Total current liabilities |
|
|
44,654 |
|
|
|
50,098 |
|
Long-term deferred revenue |
|
|
3,967 |
|
|
|
3,221 |
|
Other long-term liabilities |
|
|
201 |
|
|
|
|
|
Long-term debt and capital lease obligations |
|
|
27 |
|
|
|
986 |
|
|
|
|
|
|
|
|
Total liabilities |
|
|
48,849 |
|
|
|
54,305 |
|
Stockholders equity: |
|
|
|
|
|
|
|
|
Common
stock, $0.001 par value, 66,000 shares authorized; 21,254
shares and 20,629 shares issued, and 21,079 shares and 20,453
shares outstanding at September 30, 2006 and December 31, 2005,
respectively |
|
|
21 |
|
|
|
21 |
|
Additional paid-in capital |
|
|
120,469 |
|
|
|
115,215 |
|
Accumulated other comprehensive income |
|
|
417 |
|
|
|
85 |
|
Accumulated deficit |
|
|
(59,530 |
) |
|
|
(51,407 |
) |
Treasury stock, 176 shares, at cost |
|
|
(275 |
) |
|
|
(275 |
) |
|
|
|
|
|
|
|
Total stockholders equity |
|
|
61,102 |
|
|
|
63,639 |
|
|
|
|
|
|
|
|
Total liabilities and stockholders equity |
|
$ |
109,951 |
|
|
$ |
117,944 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements.
3
EMAGEON INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share amounts)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unaudited |
|
|
Unaudited |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, |
|
|
September 30, |
|
|
|
2006 |
|
|
2005 |
|
|
2006 |
|
|
2005 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
System sales |
|
$ |
19,754 |
|
|
$ |
13,490 |
|
|
$ |
54,624 |
|
|
$ |
34,611 |
|
Support services |
|
|
13,257 |
|
|
|
6,526 |
|
|
|
35,404 |
|
|
|
15,905 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total revenue |
|
|
33,011 |
|
|
|
20,016 |
|
|
|
90,028 |
|
|
|
50,516 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
System sales |
|
|
10,712 |
|
|
|
7,206 |
|
|
|
33,973 |
|
|
|
17,782 |
|
Support services |
|
|
6,187 |
|
|
|
3,799 |
|
|
|
18,939 |
|
|
|
10,798 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total cost of revenue |
|
|
16,899 |
|
|
|
11,005 |
|
|
|
52,912 |
|
|
|
28,580 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross profit |
|
|
16,112 |
|
|
|
9,011 |
|
|
|
37,116 |
|
|
|
21,936 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Research and development |
|
|
4,601 |
|
|
|
2,624 |
|
|
|
12,763 |
|
|
|
7,955 |
|
Sales and marketing |
|
|
4,435 |
|
|
|
2,455 |
|
|
|
13,026 |
|
|
|
7,855 |
|
General and administrative |
|
|
4,495 |
|
|
|
2,467 |
|
|
|
12,668 |
|
|
|
7,295 |
|
Amortization of intangible assets related to
Camtronics acquisition |
|
|
885 |
|
|
|
|
|
|
|
2,655 |
|
|
|
|
|
Integration costs related to Camtronics acquisition |
|
|
2,062 |
|
|
|
|
|
|
|
4,343 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total operating expenses |
|
|
16,478 |
|
|
|
7,546 |
|
|
|
45,455 |
|
|
|
23,105 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating (loss) income |
|
|
(366 |
) |
|
|
1,465 |
|
|
|
(8,339 |
) |
|
|
(1,169 |
) |
Interest income |
|
|
157 |
|
|
|
497 |
|
|
|
473 |
|
|
|
1,207 |
|
Interest expense |
|
|
(64 |
) |
|
|
(131 |
) |
|
|
(257 |
) |
|
|
(1,125 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income |
|
$ |
(273 |
) |
|
$ |
1,831 |
|
|
$ |
(8,123 |
) |
|
$ |
(1,087 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net (loss) income per share, basic and diluted |
|
$ |
(0.01 |
) |
|
$ |
0.09 |
|
|
$ |
(0.39 |
) |
|
$ |
(0.06 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
21,013 |
|
|
|
20,110 |
|
|
|
20,822 |
|
|
|
17,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted weighted average shares outstanding |
|
|
21,013 |
|
|
|
21,382 |
|
|
|
20,822 |
|
|
|
17,191 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements.
4
EMAGEON INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
|
|
|
|
|
|
|
|
|
|
|
Unaudited |
|
|
|
Nine Months Ended September 30, |
|
|
|
2006 |
|
|
2005 |
|
OPERATING ACTIVITIES |
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(8,123 |
) |
|
$ |
(1,087 |
) |
Adjustments
to reconcile net loss to net cash (used in) provided by operating activities:
|
|
|
|
|
|
|
|
|
Depreciation |
|
|
5,320 |
|
|
|
4,070 |
|
Amortization of intangible assets |
|
|
3,677 |
|
|
|
709 |
|
Write-off of subordinated debt discount |
|
|
|
|
|
|
646 |
|
Stock-based compensation expense |
|
|
2,348 |
|
|
|
918 |
|
Loss on disposal of fixed assets |
|
|
460 |
|
|
|
|
|
Other operating activities |
|
|
(49 |
) |
|
|
107 |
|
Changes in operating assets and liabilities, net |
|
|
(6,389 |
) |
|
|
(9,138 |
) |
|
|
|
|
|
|
|
Net cash used in operations |
|
|
(2,756 |
) |
|
|
(3,775 |
) |
|
|
|
|
|
|
|
INVESTING ACTIVITIES |
|
|
|
|
|
|
|
|
Purchases of property and equipment |
|
|
(4,330 |
) |
|
|
(6,204 |
) |
Purchases of marketable securities |
|
|
|
|
|
|
(59,381 |
) |
Maturities of marketable securities |
|
|
5,000 |
|
|
|
30,000 |
|
Capitalized software development costs |
|
|
(551 |
) |
|
|
(293 |
) |
Other investing activities |
|
|
55 |
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) investing activities |
|
|
174 |
|
|
|
(35,878 |
) |
|
|
|
|
|
|
|
FINANCING ACTIVITIES |
|
|
|
|
|
|
|
|
Proceeds of issuance of common stock, net of issue costs |
|
|
2,906 |
|
|
|
69,614 |
|
Proceeds of issuance of preferred stock, net of issue costs |
|
|
|
|
|
|
59 |
|
Payment of debt and capital lease obligations |
|
|
(2,083 |
) |
|
|
(5,859 |
) |
Other financing activities |
|
|
|
|
|
|
374 |
|
|
|
|
|
|
|
|
Net cash provided by financing activities |
|
|
823 |
|
|
|
64,188 |
|
|
|
|
|
|
|
|
Effect of exchange rate changes on cash |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
Net (decrease) increase in cash |
|
|
(1,758 |
) |
|
|
24,535 |
|
Cash at beginning of period |
|
|
15,520 |
|
|
|
5,994 |
|
|
|
|
|
|
|
|
Cash at end of period |
|
$ |
13,762 |
|
|
$ |
30,529 |
|
|
|
|
|
|
|
|
The accompanying notes are an integral part of these financial statements.
5
EMAGEON INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
NOTE 1. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
The accompanying unaudited condensed consolidated financial statements include the accounts of
Emageon Inc. (Emageon, or the Company) and its majority-owned subsidiaries. All significant
intercompany accounts and transactions have been eliminated in consolidation.
In the opinion of management, the accompanying financial statements contain all adjustments
(consisting of normal recurring items) necessary for a fair presentation of results for the interim
periods presented. These unaudited interim financial statements should be read in conjunction with
the audited consolidated financial statements and related notes contained in the Companys Annual
Report on Form 10-K for the year ended December 31, 2005.
Certain reclassifications have been made to prior year amounts to provide comparability with
the current year presentation.
Operating results for the three month and nine month periods ended September 30, 2006 are not
necessarily indicative of results that may be expected for the year ending December 31, 2006.
All numbers of shares and dollar amounts in the financial statements and footnotes, except per
share amounts, are expressed in thousands.
The Company has revised its presentation of expenses incurred on behalf of, and billable to, its
customers in accordance with Emerging Issues Task Force No. 01-14 to reflect those expenses in
support services cost of revenue, and reflect the related customer billing in support services
revenue. Previously, revenue from such customer billings was netted against the related expense for
presentation in the statement of operations. The effect of this revision of revenue and expense was
to increase both support services revenue and cost of revenue by $293 for the three months ended
September 30, 2006 (by $1,384 for the nine months then ended), and by $410 for the three months
ended September 30, 2005 (by $1,004 for the nine months then ended). The revision had no effect on
the Companys reported income from operations or net income for any of these periods. The
statements of operations included in this quarterly report on Form 10-Q for the three months ended
September 30, 2005, the nine months ended September 30, 2005, and the nine months ended September
30, 2006 have been revised to reflect this change in presentation.
The preparation of financial statements in conformity with accounting principles generally accepted
in the United States requires that management use judgments to make estimates and assumptions that
affect the amounts reported in the financial statements. As a result, there is some risk that
reported financial results could have been materially different had different methods, assumptions,
and estimates been used. The Company believes that of its significant accounting policies, those
related to revenue recognition, research and development costs, and intangible and other long-lived
assets may involve a higher degree of judgment and complexity than other accounting policies used
in the preparation of its consolidated financial statements. There have been no significant
changes during the nine months ended September 30, 2006 to the items disclosed as Critical
Accounting Policies and Estimates in the Companys Annual Report on Form 10-K for the year ended
December 31, 2005 or in the Companys method of application of these critical accounting policies.
6
NOTE 2. INITIAL PUBLIC OFFERING
In February 2005 the Company completed the initial public offering of its common stock, selling
5,750 shares of its common stock for proceeds, net of underwriting discount and offering expenses,
of approximately $67,200. In connection with the offering, the Company also issued 10,843 common
shares upon the automatic conversion of outstanding preferred shares, issued 537 common shares upon
the exercise of warrants to purchase its common shares, issued 171 common shares upon the release
of escrowed shares from a prior acquisition of another business, and cancelled 553 warrants to
purchase its common shares.
NOTE 3. ACQUISITIONS AND INTANGIBLE ASSETS
On November 1, 2005 the Company acquired all of the outstanding capital stock of Camtronics Medical
Systems, Ltd. (Camtronics), a developer and manufacturer of cardiology image and information
management systems, for a cash purchase price, including acquisition expenses and net of cash
acquired, of $40,359. The results of operations of Camtronics have been included in the Companys
statements of operations since the acquisition date.
The purchase price of Camtronics was allocated to the assets and liabilities of Camtronics on a
fair-value basis, including the identification and valuation of its intangible assets and the
assignment of value to goodwill. Goodwill represents, among other things, the synergistic value
and potential competitive benefits that may be realized as a result of the acquisition, any future
products that may arise from the acquired technology, and the skilled and specialized workforce
acquired. In total, intangible asset value of $11,603 and goodwill value of $17,600 related to the
Camtronics acquisition were identified and recorded. As of
July 1, 2006, the Company determined the purchase price of
Camtronics to be final and the period for allocation of that purchase
price to be completed.
Summarized below are the Companys intangible assets, which include those arising from the
Camtronics acquisition, the acquisitions of other businesses, and the capitalized portion of
costs of internally developed software. These assets are amortized on a straight-line basis over
lives ranging from one to six years, with the exception of goodwill, which is not amortized but is
tested for impairment at least annually or as circumstances arise that may indicate impairment.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
September 30, 2006 |
|
|
December 31, 2005 |
|
|
|
Gross |
|
|
|
|
|
|
Net |
|
|
Gross |
|
|
|
|
|
Net |
|
|
|
Carrying |
|
|
Total |
|
|
Carrying |
|
|
Carrying |
|
|
Total |
|
|
Carrying |
|
|
|
Amount |
|
|
Amortization |
|
|
Amount |
|
|
Amount |
|
|
Amortization |
|
|
Amount |
|
Acquired technology |
|
$ |
5,240 |
|
|
$ |
3,106 |
|
|
$ |
2,134 |
|
|
$ |
5,240 |
|
|
$ |
2,212 |
|
|
$ |
3,028 |
|
Customer relationships |
|
|
10,028 |
|
|
|
2,851 |
|
|
|
7,177 |
|
|
|
10,028 |
|
|
|
518 |
|
|
|
9,510 |
|
Trade names |
|
|
501 |
|
|
|
394 |
|
|
|
107 |
|
|
|
501 |
|
|
|
72 |
|
|
|
429 |
|
Software development
costs |
|
|
1,349 |
|
|
|
695 |
|
|
|
654 |
|
|
|
798 |
|
|
|
567 |
|
|
|
231 |
|
Goodwill |
|
|
21,355 |
|
|
|
|
|
|
|
21,355 |
|
|
|
21,079 |
|
|
|
|
|
|
|
21,079 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
38,473 |
|
|
$ |
7,046 |
|
|
$ |
31,427 |
|
|
$ |
37,646 |
|
|
$ |
3,369 |
|
|
$ |
34,277 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average amortization periods are 4.6 years for acquired technology, 4.9 years for
customer relationships, 1.2 years for trade names, and 1.5 years for software development costs.
Amortization
expense was $2,007 for the year ended December 31, 2005 and
$3,677 for the nine months
ended September 30, 2006. Estimated future amortization expense is as follows:
7
|
|
|
|
|
Three months
ending December 31, 2006 |
|
$ |
1,307 |
|
2007 |
|
|
3,103 |
|
2008 |
|
|
2,027 |
|
2009 |
|
|
1,381 |
|
2010 and thereafter |
|
|
2,254 |
|
|
|
|
|
Total |
|
$ |
10,072 |
|
|
|
|
|
During the
third quarter of 2006 the Company, as part of the integration of
Camtronics into the operations of the Company, vacated a leased
facility and combined the operations formerly at that facility with
those at a location acquired in the Camtronics acquisition. The
Company has estimated and recorded a future net negative cash flow of
$588 expected to arise from the continuing lease obligation, and
has identified and written-off $266 representing the net book value
of property, plant and equipment items attendant to the former
facility. Both of these charges are included in Integration
costs related to Camtronics acquisition in the third quarter
2006 statement of operations. The estimated future liability for
lease payments is included in other accrued expenses and other
long-term liabilities in the September 30, 2006 balance sheet.
The Company is attempting to sub-lease the facility to another
occupant and to otherwise minimize expense related to the facility.
NOTE 4. MARKETABLE SECURITIES
At December 31, 2005 the Company held marketable debt securities classified as available-for-sale
and carried at estimated fair market value, consisting of U.S. government agency securities, in the
amount of $4,951. These securities matured during the quarter ended March 31, 2006.
NOTE 5. INVENTORIES
Inventories include the costs of materials, labor, and overhead. The costs of purchased third-party
hardware and software associated with customer sales contracts are included as inventory in the
consolidated balance sheet and charged to system sales cost of revenue in the statement of
operations once customer acceptance has been received and all other revenue recognition criteria
have been met. Inventories consist of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30,
2006 |
|
|
December 31,
2005 |
|
Third-party components |
|
$ |
3,352 |
|
|
$ |
1,708 |
|
Work-in-process |
|
|
230 |
|
|
|
345 |
|
Completed systems |
|
|
6,293 |
|
|
|
5,978 |
|
|
|
|
|
|
|
|
Total |
|
$ |
9,875 |
|
|
$ |
8,031 |
|
|
|
|
|
|
|
|
NOTE 6. SUPPLEMENTARY CASH FLOW INFORMATION
Changes in operating assets and liabilities of the Company, net of the effects of acquisitions of
other businesses, in reconciling net loss to net cash provided by or used in operations are as
follows:
|
|
|
|
|
|
|
|
|
|
|
Nine Months Ended September 30, |
|
|
|
2006 |
|
|
2005 |
|
(Increase) decrease in: |
|
|
|
|
|
|
|
|
Trade accounts receivable, net |
|
$ |
(698 |
) |
|
$ |
(3,738 |
) |
Inventories, net |
|
|
(1,844 |
) |
|
|
31 |
|
Prepaid expenses and other current assets |
|
|
(722 |
) |
|
|
(1,827 |
) |
Other noncurrent assets |
|
|
(228 |
) |
|
|
(54 |
) |
|
|
|
|
|
|
|
|
|
Increase (decrease) in: |
|
|
|
|
|
|
|
|
Accounts payable |
|
|
(3,911 |
) |
|
|
1,466 |
|
Accrued payroll and related costs |
|
|
(657 |
) |
|
|
(310 |
) |
Other accrued expenses |
|
|
333 |
|
|
|
(1,697 |
) |
Deferred revenue |
|
|
1,338 |
|
|
|
(3,009 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net changes in operating assets and liabilities |
|
$ |
(6,389 |
) |
|
$ |
(9,138 |
) |
|
|
|
|
|
|
|
8
There were no significant non-cash investing and financing transactions in the nine month
periods ended September 30, 2006 and 2005.
NOTE 7. COMPUTATION OF EARNINGS PER SHARE
Basic net income or loss per share is computed using the weighted average common shares outstanding
during the period. Diluted net income or loss per share is computed using the weighted average
common shares and common share equivalents outstanding during the period. Common share equivalents
consisted of convertible preferred stock, common stock warrants, and options to purchase common
stock granted to employees and directors (stock options) during the nine months ended September
30, 2005, and consisted of common stock warrants and stock options during the nine months ended
September 30, 2006. Common stock equivalents consisting of 1,931 shares as of September 30, 2006
were excluded from the loss per share computations for the three and nine month periods ended
September 30, 2006 because their inclusion would have been anti-dilutive. Common stock equivalents
consisting of 2,224 shares as of September 30, 2005 were included in the net income per share
computation for the three months ended September 30, 2005, but excluded from the net loss per share
computation for the nine months then ended because their inclusion would have been anti-dilutive.
NOTE 8. STOCK BASED COMPENSATION
The Companys stock-based compensation plans are administered by the Compensation Committee of the
Board of Directors, which selects persons eligible to receive awards, determines the number of
shares and/or options subject to each award, and determines the terms, conditions, performance
measures, and other provisions of the award. Note 16 of the Companys consolidated financial
statements included in its Annual Report on Form 10-K for the year ended December 31, 2005 contains
additional information related to these stock-based compensation plans.
Effective January 1, 2006, the Company adopted Statement of Financial Accounting Standards No. 123
(revised), Share-Based Payment (SFAS 123R) utilizing the modified prospective approach. Prior to
the adoption of SFAS 123R, the Company accounted for stock option grants in accordance with APB
Opinion No. 25, Accounting for Stock Issued to Employees (the intrinsic value method), and
accordingly recognized no compensation expense for stock options that were granted with exercise prices at or above
the fair
market value of the Companys common stock on the date of grant.
The provisions of SFAS 123R are applied to awards granted after its effective date and to awards
outstanding at the effective date that are subsequently modified, repurchased or cancelled. Under
the modified prospective approach, compensation cost to be recognized includes compensation cost
for all share-based awards granted prior to, but not yet vested as of the effective date, based on
the grant-date fair value estimated in accordance with the original provisions of SFAS 123, and
includes compensation cost for all share-based awards granted subsequent to the effective date
based on the grant-date fair value estimated in accordance with the provisions of SFAS 123R. As
allowed by SFAS 123R, the Company elected not to restate periods prior to the effective date to
reflect the impact of adopting the new standard.
As a result of adopting SFAS 123R on January 1, 2006, the Companys net loss and basic and diluted
earnings per share for the quarter ended September 30, 2006 were $700 or $0.03 lower,
respectively, and $1,500 or
9
$0.07 lower for the nine months ended September 30, 2006, respectively, than if the Company had
continued to account for stock-based compensation under APB Opinion No. 25.
Net cash proceeds from the exercise of
stock options were $800 for the quarter ended
September 30, 2006, and $2,900 for the nine months ended September 30, 2006.
The following table illustrates the effect
on earnings and earnings per share for the quarter and
nine months ended September 30, 2005 had the Company accounted for stock-based compensation in
accordance with SFAS 123R for those periods:
10
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
September 30, 2005 |
|
|
September 30, 2005 |
|
Net income (loss): |
|
|
|
|
|
|
|
|
As reported |
|
$ |
1,831 |
|
|
$ |
(1,087 |
) |
Add: Stock-based employee compensation
reported in net income (loss) |
|
|
301 |
|
|
|
918 |
|
Deduct: Stock-based employee
compensation under the fair value method
for all awards |
|
|
(488 |
) |
|
|
(1,427 |
) |
|
|
|
|
|
|
|
Pro forma net income (loss) |
|
$ |
1,644 |
|
|
$ |
(1,596 |
) |
|
|
|
|
|
|
|
Basic and diluted net income (loss) per share: |
|
|
|
|
|
|
|
|
As reported |
|
$ |
0.09 |
|
|
$ |
(0.06 |
) |
Add: Stock-based employee compensation
reported in net income (loss) |
|
|
0.01 |
|
|
|
0.05 |
|
Deduct: Stock-based employee
compensation under the fair value method
for all awards |
|
|
(0 .02 |
) |
|
|
(0.08 |
) |
|
|
|
|
|
|
|
Pro forma net income (loss) per share |
|
$ |
0.08 |
|
|
$ |
(0.09 |
) |
|
|
|
|
|
|
|
Stock Options
The Company used the Black-Scholes option pricing model to estimate the fair value of stock-based
awards utilizing the following assumptions for the quarter and nine months ended September 30, 2005
and 2006.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended |
|
Three Months Ended |
|
Nine Months Ended |
|
Nine Months Ended |
|
|
September 30, 2005 |
|
September 30, 2006 |
|
September 30, 2005 |
|
September 30, 2006 |
Dividend yield |
|
|
0.0 |
% |
|
|
0.0 |
% |
|
|
0.0 |
% |
|
|
0.0 |
% |
Expected volatility |
|
|
70.9 |
% |
|
|
70.9 |
% |
|
|
70.9 |
% |
|
|
70.9 |
% |
Risk-free interest rate |
|
|
4.06 |
% |
|
|
5.02 |
% |
|
|
3.81 |
% |
|
|
4.87 |
% |
Expected life of options, in years |
|
|
5.0 |
|
|
|
5.0 |
|
|
|
5.0 |
|
|
|
5.0 |
|
Weighted average grant date fair value |
|
$ |
8.10 |
|
|
$ |
9.38 |
|
|
$ |
9.08 |
|
|
$ |
9.61 |
|
11
The assumptions above are based on multiple factors, including historical exercise patterns of
employees in relatively homogeneous groups with respect to exercise and post-vesting employment
termination behaviors, expected future exercising patterns for these same homogeneous groups, and
the volatility of the Companys stock price.
At September 30, 2006, there
was $6,800 of unrecognized compensation cost related to
share-based payments. The Company expects this compensation cost to be recognized over a
weighted-average period of 2.84 years.
The following table represents stock option activity for the three and nine month periods ended
September 30, 2006:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average |
|
|
|
|
|
|
Weighted-Average |
|
|
Remaining |
|
Three Months Ended September 30, 2006 |
|
Number of Shares |
|
|
Exercise Price |
|
|
Contractual Life |
|
Options at beginning of period |
|
|
2,115 |
|
|
$ |
8.63 |
|
|
|
|
|
Granted |
|
|
31 |
|
|
|
15.10 |
|
|
|
|
|
Exercised |
|
|
(154 |
) |
|
|
5.07 |
|
|
|
|
|
Forfeited |
|
|
(97 |
) |
|
|
10.54 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of period |
|
|
1,895 |
|
|
$ |
8.93 |
|
|
7.31 years |
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at end of period |
|
|
967 |
|
|
$ |
4.75 |
|
|
5.60 years |
|
|
|
|
|
|
|
|
|
|
|
|
Nonvested stock options |
|
|
928 |
|
|
$ |
13.29 |
|
|
9.08 years |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted-Average |
|
|
|
|
|
|
Weighted-Average |
| |
Remaining |
Nine Months Ended September 30, 2006 |
|
Number of Shares |
| |
Exercise Price |
| |
Contractual Life |
Options at beginning of period |
|
|
2,129 |
|
|
$ |
5.91 |
|
|
|
|
|
Granted |
|
|
530 |
|
|
|
16.18 |
|
|
|
|
|
Exercised |
|
|
(613 |
) |
|
|
4.66 |
|
|
|
|
|
Forfeited |
|
|
(151 |
) |
|
|
9.14 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of period |
|
|
1,895 |
|
|
|
8.93 |
|
|
7.31 years |
|
|
|
|
|
|
|
|
|
|
Exercisable at end of period |
|
|
967 |
|
|
|
4.75 |
|
|
5.60 years |
|
|
|
|
|
|
|
|
|
|
Shares available for future stock option grants
to employees and directors under existing plans
were 2,513 and 433, respectively, at September 30, 2006. At September 30, 2006, the aggregate
intrinsic value of options outstanding was $12,600, and the aggregate intrinsic value of
options exercisable was $10,500. Total intrinsic value of options exercised was $1,500
for the three months ended September 30, 2006 and $7,200 for the nine months ended
September 30, 2006.
12
Restricted Stock
The Companys plans allow for the issuance of restricted stock awards that may not be sold or
otherwise transferred until certain restrictions have lapsed. The unearned stock-based compensation
related to these awards is being amortized to compensation expense over a period of four years,
equal to the period over which the restrictions lapse. The share based expense for these awards was
determined based on the market price of the Companys stock at the date of grant applied to the
total number of shares that were anticipated to fully vest and then amortized over the vesting
period.
During the third quarter of 2006, the Company granted 5 shares of restricted stock (57 shares for
the nine months ended September 30, 2006), all of which were outstanding and unvested at September
30, 2006.
NOTE 9. COMPREHENSIVE LOSS
The Companys comprehensive loss differs from its reported net loss due to non-equity items
consisting of foreign currency translation adjustments and unrealized gains and losses on
available-for-sale marketable securities. Comprehensive loss for the quarter ended September 30,
2006 was $274 and for the nine months ended September 30, 2006
was $7,792. For the quarter and nine
months ended September 30, 2005, comprehensive income and loss, respectively, were equal to the net
income and loss reported in the Companys statement of operations for those periods. Net
accumulated comprehensive income adjustments as of September 30, 2006 are $417.
NOTE
10. RECENT ACCOUNTING PRONOUNCEMENTS
In June 2006 the Financial Accounting Standards Board issued its
Interpretation No. 48, Accounting For Uncertainty in Income
Taxes (Interpretation No. 48), and in September 2006
issued Statement of Financial Accounting Standards No. 157, Fair
Value Measurements (SFAS No. 157). Interpretation No. 48, which is
effective for the Companys fiscal year ending
December 31, 2007, prescribes a recognition threshold and measurement
attribute for financial statement recognition and measurement of a
tax position taken or expected to be taken in a tax return. SFAS No. 157, which
is effective for the Companys fiscal year ending
December 31, 2008, defines fair value, establishes a framework for
measuring fair value under generally accepted accounting principles,
and expands disclosure about fair value measurements. The Company is
evaluating these pronouncements to determine any effects on the
Companys reported financial position and results of operations,
but does not currently believe that these pronouncements will have a
material effect on its financial statements.
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
FORWARD-LOOKING STATEMENTS
Some of the statements made in this Quarterly Report on Form 10-Q contain forward-looking
statements which reflect the Companys plans, beliefs, and current views with respect to, among
other things, future events and financial performance. These statements are often identified by
use of forward-looking words such as believe, expect, potential, continue, may, will,
should, could, would, intend, plan, estimate, anticipate, and comparable words or the
negative version of these and other words. Any forward-looking statement contained in this Form
10-Q is based upon the Companys historical performance and on current plans, estimates, and
expectations. The inclusion of this forward-looking information should not be regarded as a
representation by the Company or any other person that the future plans, estimates, or expectations
contemplated by the Company will be achieved. Such forward-looking statements are subject to
various risks and uncertainties. In addition, there are or will be important factors that could
cause actual results to differ materially from those indicated in the statements. These factors
include, but are not limited to, those described in Item 1A of the Companys Annual Report on Form
10-K for the year ended December 31, 2005 under the caption Risk Factors.
This cautionary statement should not be regarded as exhaustive and should be read in
conjunction with other cautionary statements and other information contained in the Companys
Annual Report on Form 10-K for the year ended December 31, 2005. The Company operates in a
continually changing business environment, and new risks and uncertainties emerge from time to
time. Management cannot predict these new risks and uncertainties, nor can it assess the impact,
if any, that any such risks and uncertainties may have on the Companys business or the extent to
which any factor or combination of factors may cause actual results to differ from those projected
in any forward-looking statement. Accordingly, the risks and uncertainties to which the Company is
subject can be expected to change over time, and the Company undertakes no obligation to update
publicly or review the risks or uncertainties described herein or in the Companys Annual Report on
Form 10-K for the year ended December 31, 2005. The Company also undertakes no obligation to
update publicly or review any of the forward-looking statements made in this Form 10-Q, whether as
a result of new information, future developments, or otherwise.
13
This Managements Discussion and Analysis of Financial Condition and Results of Operations
section should be read in conjunction with the unaudited financial statements and footnotes
appearing in Part I of this Form 10-Q and the audited financial statements included in the
Companys Annual Report on Form 10-K for the year ended December 31, 2005.
COMPANY OVERVIEW
Emageon provides an enterprise-level information technology solution for the clinical analysis
and management of digital medical images within multi-hospital networks, community hospitals, and
diagnostic imaging centers. The Companys solution consists of advanced visualization and image
management software, third-party components, and comprehensive support services. The Companys
web-enabled advanced visualization software, which is hosted by the customer, provides physicians
across the enterprise, in multiple medical specialties and at any network access point, with
dynamic tools to manipulate and analyze images in both a two dimensional and three dimensional
perspective. With these tools, physicians have the ability to better understand internal anatomic
structure and pathology, which can improve clinical diagnoses, disease screening, and therapy
planning. The Companys open standard solution is designed to help customers improve staff
productivity, enhance revenue opportunities, automate complex medical imaging workflow, lower total
cost of ownership, and provide better service to physicians and patients.
RESULTS SUMMARY
Revenue for the three months ended September 30, 2006 (the Companys third fiscal quarter of
2006) was a record $33.0 million, a 65% increase over the third quarter of 2005. For the nine
months ended September 30, 2006, total revenue was $90.0 million, a 78% increase over the
comparable prior year period. The net loss for the third quarter was
$0.3 million, or $0.01 per share,
compared to a net income of $1.8 million, or $0.09 per share, in the third
quarter of 2005. For the nine months ended September 30, 2006, the Companys net loss was $8.1
million, or $0.39 per share, compared to a net loss of $1.1 million, or $0.06 per share, in the
first nine months of 2005.
As explained in the individual sections of this Managements Discussion and Analysis of
Financial Condition and Results of Operations, the acquisition of Camtronics Medical Systems, Ltd.
on November 1, 2005, which added a cardiology line of products to the Companys product offering,
accounts for much of the change in the individual categories of revenue and expense described in
this section.
Included in the results of the Company for the three month and nine month periods ended
September 30, 2006 are the following:
|
1) |
|
Third quarter expenses of $2.1 million, or $0.10 per share, related to the integration
of Camtronics with the Company ($4.3 million, or $0.21 per share, for the nine months ended
September 30, 2006), |
|
|
2) |
|
Third quarter non-cash expenses of $1.0 million, or $0.05 per share, in amortization of
intangible assets acquired in the Camtronics acquisition,
($2.9 million, or $0.14 per
share, for the nine months ended September 30, 2006), and |
|
|
3) |
|
Third quarter non-cash expenses of $1.0 million, or $0.05 per share, for stock
options-based compensation after the Companys adoption of Statement of Financial
Accounting Standards No. 123R as of January 1, 2006 ($2.3 million, or $0.11 per share, for
the nine months ended September 30, 2006). |
Cash used
in operations in the third quarter of 2006 was $0.1 million and for the nine months
ended September 30, 2006, was $2.8 million. At September 30, 2006 the Company had $13.8 million
in unrestricted cash and cash equivalents, and had not drawn on its
$10 million secured line of credit with a
bank.
14
Revenue and Gross Margin
Revenue consists of system sales and support services revenue. System sales revenue is
comprised of revenue from sales of the Companys software and third-party components, primarily
computer hardware. Costs of system sales revenue consist of purchases of hardware and software from
third party vendors for use by customers and the Companys
manufacturing and distribution costs.
Software development expenses are generally included in research and development expense in the
Companys statement of operations.
Support services revenue is comprised of revenue from professional services such as
implementation and training, as well as ongoing maintenance services. Costs of support services
revenue consist of labor, overhead, and associated costs of implementation, installation, and
training on behalf of customers, and the costs of providing continuous support of hardware and
software sold to customers.
Individual radiology system sales typically
are larger in terms of both sales dollars and
required implementation time than individual cardiology system sales. In any given period, the mix
of total system sales revenue to total support services revenue, the mix of hardware and software
comprising system sales revenue, and the mix of radiology revenue to cardiology revenue can
produce significant variability in the levels of revenue and gross margin reported.
The following table sets forth comparative revenue and gross margin data for the three and
nine month periods ended September 30, 2006 and 2005.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In Thousands) |
|
|
|
Three Months Ended |
|
|
Nine Months Ended |
|
|
|
Sept. 30, |
|
|
Sept. 30, |
|
|
|
2006 |
|
|
2005 |
|
|
2006 |
|
|
2005 |
|
Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
System sales |
|
$ |
19,754 |
|
|
$ |
13,490 |
|
|
$ |
54,624 |
|
|
$ |
34,611 |
|
Support services |
|
|
13,257 |
|
|
|
6,526 |
|
|
|
35,404 |
|
|
|
15,905 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
33,011 |
|
|
|
20,016 |
|
|
|
90,028 |
|
|
|
50,516 |
|
Cost of Revenue: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
System sales |
|
|
10,712 |
|
|
|
7,206 |
|
|
|
33,973 |
|
|
|
17,782 |
|
Support services |
|
|
6,187 |
|
|
|
3,799 |
|
|
|
18,939 |
|
|
|
10,798 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
16,899 |
|
|
|
11,005 |
|
|
|
52,912 |
|
|
|
28,580 |
|
Gross Profit: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
System sales |
|
|
9,042 |
|
|
|
6,284 |
|
|
|
20,651 |
|
|
|
16,829 |
|
Support services |
|
|
7,070 |
|
|
|
2,727 |
|
|
|
16,465 |
|
|
|
5,107 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
$ |
16,112 |
|
|
$ |
9,011 |
|
|
$ |
37,116 |
|
|
$ |
21,936 |
|
Gross Margin: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
System sales |
|
|
45.7 |
% |
|
|
46.6 |
% |
|
|
37.8 |
% |
|
|
48.6 |
% |
Support services |
|
|
53.3 |
% |
|
|
41.8 |
% |
|
|
46.5 |
% |
|
|
32.1 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total |
|
|
48.8 |
% |
|
|
45.0 |
% |
|
|
41.2 |
% |
|
|
43.4 |
% |
Summary. Total revenue in third quarter 2006 was a record $33.0 million, a 65% increase over
third quarter 2005. For the nine months ended September 30, 2006, total revenue was $90.0 million,
a 78% increase over the comparable prior year period. These increases in revenue reflect both the
organic growth of the Company and the results of its acquisition of Camtronics and its cardiology line of products
on November 1, 2005. Year over year gross margin earned on total revenue declined by 2.2
percentage points. Gross margin earned in the first nine months of 2006 has been reduced by low
first quarter margin caused by higher third-party hardware content in systems installed, and by
the Companys acquisition of other
businesses, in which revenue previously deferred by an acquired company is recognized
post-acquisition by the acquiring
15
company at minimal gross margin. Both second and third quarter
2006 gross margin trended higher than the year to date level for the reasons discussed below.
Sequentially,
third quarter 2006 total revenues were up by $3.0 million, or 10.0%, over the second
quarter of the year, and up by $6.0 million, or 22.3%, over the first quarter of the year.
The two components of the Companys revenue and gross margin are discussed individually below in
comparison to prior year periods.
System
Sales Revenue. Third quarter 2006 system sales revenue exceeded the comparable 2005 period by
$6.3 million, or 46.4%. The Companys acquisition of
Camtronics was the
primary reason for the increase.
Camtronics revenue improved
significantly in the third quarter compared to the first two
quarters of 2006 as customer acceptances were received on orders
placed after the acquisition of Camtronics
by the Company.
System sales revenue for the nine months ended September 30, 2006 exceeded the comparable prior
year period by $20.0 million, or 57.8%. The Companys
acquisition of Camtronics contributed
significantly to the year over year increase, and the Companys
legacy products grew as well, reflecting greater numbers of
installations for both new customers and existing customers
and greater acceptance of the Companys products in the marketplace, particularly with
multi-facility healthcare providers. The first half of 2006 contained two individually significant installations of radiology systems and related
revenue recognition. Growth in legacy products in
2006 was negatively impacted
on a comparative basis by the 2005 recognition of approximately
$3.4 million in revenue that had been deferred in
2004 pending delivery of upgrades and completion of other commitments to customers.
System
Sales Gross Margin. The Companys system sales gross margin was 45.7% for third quarter
2006. Third quarter 2005 system sales gross margin, which contained
no cardiology revenue attributable to the Companys
acquisition of Camtronics in November, 2005, was unusually high at 46.6% as the result of
the recognition of revenue at a major customer installation
which had been previously deferred pending delivery of
software upgrades. The decline of 0.9 percentage points quarter to quarter is the result of the
addition of cardiology revenue to the mix of total systems revenue
for third quarter of 2006
and a lower mix of software to
hardware revenue in third quarter 2006 than in 2005, which tended to lower overall system sales
gross margin. Sequentially, third quarter system sales gross margin was two percentage points
higher than in second quarter 2006 as the result of a return of cardiology system revenue and
gross margin to more normal levels after
the lower margins recorded in earlier quarters.
For the
nine months ended September 30, 2006, system sales gross margin
was 37.8% compared to 48.6% for the same period in 2005. The current
year to date system sales gross
margin was lowered by the Companys unusually low first quarter gross margin of 23.1%, which was
the result of high hardware content versus software content in the systems sold. That mix returned
to a more normal level in the second and third quarter, resulting in a 43.3% gross margin for second
quarter 2006 and a 45.7% system sales gross margin for third quarter
2006. System sales gross margin for the nine months ended
September 30, 2005 was unusually high for the reasons described above.
In
general, the costs of third party hardware components tend to lower
the Companys system sales gross
margin. The Company expects system sales gross margins in the low-to-mid forty percent range going
forward, assuming a normal mix of hardware versus software and radiology versus cardiology
revenues. However, the Companys system sales gross margin may significantly fluctuate from quarter to
quarter depending on the mix of revenue recognized in a given reporting period and other factors.
Support Services Revenue. The Companys support services revenue increased by $6.7 million, or
103.1%, in third quarter 2006 compared to the prior year period. The
Companys acquisition of Camtronics in November 2005 contributed significantly to the quarter to quarter
increase, and support services revenue related to the Companys legacy products grew substantially
as well. Support services revenue, which consists primarily of system installation services,
customer training, and system maintenance services, is ancillary to
the Companys system sales revenues
and therefore tends to grow as system sales revenue grows. Third quarter 2006 support services revenue
was characterized by an increased number of system installations compared to third quarter 2005.
In addition, the Companys system maintenance revenue grew quarter to quarter with the higher
number of system installations and
16
higher number of customers subscribing to the Companys
maintenance services, including cardiology customers assimilated into the Company as a result of
the Camtronics acquisition. Sequentially, support services revenue was $0.8 million, or 6.8%,
higher in third quarter 2006 than in second quarter 2006, and $3.5 million, or 36.2%, higher in
third quarter than in first quarter 2006.
Support services revenue grew by $19.5 million, or 122.6%, in the nine months ended September 30,
2006 compared to the same prior year period. The increase is due in
part to the Companys acquisition of Camtronics in November 2005, but also reflects the Companys growth in both
cardiology and legacy systems sales revenue. Such systems sales revenue increases have and are
expected to continue to bring increases in revenue from the Companys installation and training
capabilities, as well as increased maintenance revenue from an increasing installed base of
customers.
Support Services Gross Margin. The Companys
support services gross margin was 53.3% in third
quarter 2006, an 11.5 point increase over the third quarter 2005
level. The improvement in third quarter 2006
margin is partially the result of the installation of a greater
number of systems in the quarter.
In addition, cardiology support services revenue has historically earned
slightly higher gross margins than the Companys legacy products, increasing the overall support
services gross margin. The timing of closure of individual
system installations
from period to period can
significantly impact the level of support services revenue and gross margin reported for a given
period. In addition, the Company believes that its support services gross margin is higher for both
the third quarter and nine months ended September 30, 2006 as the result of gradually increasing
labor and other efficiencies in its installation, training, and maintenance activities as the fixed
cost of these services is spread over a larger installed base of customers.
In addition to the factors described above,
the Company believes that both its third quarter and
nine months ended September 30, 2005 support services gross margin was lowered by the
commencement of a build-up in the relevant staffing levels, and that the efficiency of that staff
has begun to increase with growth of the installed base in 2006. With
its current mix of business, the Company
expects support services gross
margin percentage to be slightly higher than the system sales gross margin
percentage,
assuming its staff
efficiencies continue and its cardiology business continues to deliver margins at the current
level, but also expects some timing-based variability in support services gross margin from period
to period.
Research & Development, Sales & Marketing, and General & Administrative Expenses
Total research and development, sales and marketing,
and general and administrative expenses for
the quarter ended September 30, 2006 were $13.5 million as compared to $7.5 million in the
corresponding prior year period, an increase of $6.0 million or
79.3%. The addition of the
operating expenses of Camtronics, which was acquired by the Company
on November 1, 2005, accounts for
the majority of the total increase, with the remainder of the increase consisting of (a) increased
general and administrative expenses resulting from the Companys status as a publicly held entity,
specifically the costs of compliance with the Sarbanes-Oxley Act of
2002, b) stock-based compensation expense, and (c) increased overhead expenses consistent with the
Companys growth and increased marketing expenses in support of expanded marketing efforts. The
growth of 79.3% in these expenses quarter to quarter compares to total revenue growth over the same
period of 64.9% and growth in gross margin of 78.9%. As a percentage of revenue, these expenses were
41.0% in third quarter 2006
compared to 37.7% in third quarter 2005.
For the nine months ended September 30, 2006, total research and development, sales and marketing,
and general and administrative expenses were $38.5 million as compared to $23.1 million in the
corresponding prior year period, an increase of $15.4 million or
66.4%. The addition of the
operating expenses of Camtronics accounts for the majority of the total increase, with the
remainder of the increase consisting of increased general and administrative, stock compensation,
and overhead and marketing expenses as described for the third quarter above. Overall, these
expenses grew 66% in the first nine months of 2006 while total
revenue grew 78% and gross margin grew 69% over the same
period. As a percentage of revenue, these expenses were 42.7% in the nine months ended September
30, 2006, compared to 45.7% in the comparable prior year period.
The Company expects that its research and development, sales and marketing, and general and
administrative expenses will continue to grow as its revenue grows and as it addresses new product
markets, but doesnt expect growth in excess of its rate of revenue growth over the long-term.
17
Research and Development Expenses. Research and development expenses increased by $2.0 million, or
75.3%, in third quarter 2006 compared to third quarter 2005. The addition of Camtronics and its
employee headcount and cardiology development efforts accounts for the majority of the quarter to
quarter increase, with the remainder consisting primarily of higher overhead and depreciation
charges, increased consulting and other costs resulting from
software development efforts
in
2006, and stock-based compensation expense. As a percentage of revenue, research and development
expenses were 13.9% in third quarter 2006 compared to 13.1% in third quarter 2005.
For the nine months ended September 30, 2006, research and development expenses increased by $4.8
million, or 60.4%, over the prior year period. The addition of Camtronics and its employee
headcount and cardiology development efforts accounts for the majority of the increase, with
the remainder due to costs related to new software releases, increased depreciation charges, and
stock-based compensation, all as described above for third quarter 2006. As a percentage of
revenue, research and development expenses were 14.2% in the first nine months of 2006 compared to
15.7% in the first nine months of 2005.
Sales
and Marketing Expenses. Sales and marketing expenses increased by
$2.0 million, or 80.7%, in
third quarter 2006 compared to third quarter 2005. The addition of Camtronics and its employee
headcount, its cardiology selling efforts, and the efforts of the combined companies to begin
cross-market selling had the greatest impact on the third quarter increase, with the remainder due
to higher marketing expenses, such as advertising and trade shows, and stock-based compensation.
As a percentage of revenue, sales and marketing expenses were 13.4% in third quarter 2006 compared
to 12.3% in third quarter 2005.
For the nine months ended September 30, 2006, sales and marketing expenses increased by $5.2
million, or 65.8%, over the prior year period. The addition of Camtronics and its employee
headcount, its cardiology selling efforts, and the combined companys effort to cross-market sell
its products accounts for the majority of the year to date increase, with the remainder consisting
of higher marketing expenses and stock compensation expenses as described above. As a percentage of
revenue, sales and marketing expenses were 14.5% in the first nine months of 2006 compared to 15.5%
in the first nine months of 2005.
General and Administrative Expenses. General and administrative expenses increased by $2.0 million,
or 82.2%, in third quarter 2006 compared to third quarter 2005. The increase is due primarily to
an increasing level of audit, legal, and consulting and other expenses incurred to become compliant in
2006, as required, with the Sarbanes-Oxley Act of 2002, to administrative headcount and related
increases in support of the Companys revenue growth, and to stock-based compensation expense. As
a percentage of revenue, general and administrative expenses were 13.6% in third quarter 2006
compared to 12.3% in third quarter 2005.
For the nine months ended September 30, 2006, general and administrative expenses increased by $5.4
million, or 73.7%, over the prior year period. This increase is due to higher expenses as
described in the third quarter discussion above. As a percentage of revenue, general and
administrative expenses were 14.1% in the first nine months of 2006 compared to 14.4% in the prior
year period.
LIQUIDITY AND CAPITAL RESOURCES
Summary. The Companys unrestricted cash, cash equivalents, and marketable securities at September
30, 2006 totaled $13.8 million, a decline of approximately $6.7 million since December 31, 2005.
This decline is primarily the result of funding of the Companys net loss for the first nine months
of the year, but also includes the effects of investment in property, plant, and equipment of $4.3
million, including the upgrade and remodeling of the former Camtronics headquarters building and
computer hardware and software for internal use, and the payment of scheduled debt installments of
$2.1 million, offset by the proceeds of stock option exercises by employees of $2.9 million. Total
debt remained minimal at $1.7 million, and the Company has not drawn on its $10 million line of
credit. In addition, revenue for the second and third quarters of 2006 were at record levels,
with accounts receivable at September 30, 2006 of $30.0 million net of the allowance for doubtful
accounts. The Company believes that its existing cash balances, together with its
future cash flows and the availability of funding under its line of credit, if necessary, will be
sufficient to fund its operations for the next twelve month period.
18
Cash Used In Operating Activities. Net cash used in operations for the nine months ended September
30, 2006 was $2.8 million, compared to a net usage of cash from operations in the nine months ended
September 30, 2005 of $3.8 million. The net use of cash in first nine months of 2006 is primarily
the result of the Companys net loss for the period, but also includes the effects of an accounts
receivable increase of $0.7 million and an inventory increase of $1.8 million, both reflecting
higher revenue levels, and a $4.3 million decrease in accounts payable and accrued liabilities
resulting from the timing of expenditures.
The net use of cash of $3.8 million
in the nine months ended September 30, 2005 was the result
primarily of that periods net loss of $1.1 million, but also reflected increased accounts
receivable as the result of the timing of customer acceptances and new customer contracts,
increased prepaid expenses as the result of the payment of numerous annual hardware maintenance
contracts on customers hardware components, and decreased deferred revenue as the result of
recognition of previously deferred revenue as installations were completed and customer commitments were
met.
Cash from operating activities in a
given period is most affected by the Companys net income or
loss for the period, by the timing of billings to customers compared to the timing of revenue
recognition, and by the timing of receipt and delivery of sales orders, which can temporarily
affect the levels of inventory and accounts payable and similar liabilities. The Company was cash
flow positive from operations over its combined second and third quarters of 2006, and
expects cash flow from operations to be positive over the long-term.
The Company further expects that its funding of activities related
to the integration of operations with Camtronics will be substantially completed during the fourth
quarter of 2006.
Cash From Investing Activities. Net cash
provided by investing activities was $0.2 million in the
nine months ended September 30, 2006 compared to a net use of cash in investing activities of
$35.9 million in the same prior year period. Provision of cash from investing
activities for the first nine months of 2006 consisted primarily of the maturity of $5.0 million
of marketable securities, the
proceeds of which were used to finance operating activities, and a use of cash of $4.3 million for
capital expenditures, including the upgrade and remodeling of the Camtronics headquarters building
and the purchase of computer hardware and software for internal use. In addition, the Company
expended $0.6 million on the capitalized portion of its software development costs in the nine
months ended September 30, 2006.
In the first nine months of 2005, net use
of cash consisted of the purchase of marketable
securities of $59.4 million, reflecting the investment of part of the funds raised in the Companys
initial public offering, and the purchase of $6.2 million in property and equipment items for
research and development, quality assurance, to equip new employees, and to purchase third party
hardware components for contracted customer sites, all of which were offset by the maturity of
$30.0 million in marketable securities.
The Company expects that purchases of
property and equipment will continue to grow as its customer base, resulting employee headcount, and its research
and development activities continue to grow.
Cash From Financing Activities. Net cash provided by financing activities was $0.8 million for the
nine months ended September 30, 2006 compared to $64.2 million in first nine months of 2005. In
the first nine months of 2006, the Company received proceeds of $2.9 million on the exercise of stock
options, and made regularly scheduled payments of $2.1 million on its outstanding debt.
Cash provided by financing activities in the first nine months of 2005 was the result of the
Companys initial public offering of its stock in February 2005, less the payment of debt of $5.9
million.
Contractual Cash Obligations. As of
September 30, 2006 the Company had total obligations for the
payment of cash of approximately $8.4 million, consisting of $1.7 million in debt and capital lease
obligations and $6.7 million in operating lease commitments, primarily for office space. Under
their present terms, these obligations come due in the amounts of approximately $3.2 million in
less than one year, $3.1 million in one to three years, and $2.1 million in three years and beyond.
19
Available Credit. In April of 2006, the Company entered into an agreement with a bank that provides
available credit of $10.0 million at the banks prime interest rate. The agreement is for a term
of two years, at the end of which all amounts become due and payable. Security for any amounts
borrowed under the agreement consists of all assets of the Company other than its intellectual
property and real estate. At September 30, 2006 there were no amounts outstanding under the line
of credit.
The Company believes that existing cash, together with its future cash flows and amounts available
under its loan and security agreement, if necessary, will be sufficient to execute its business
plan for the next twelve months. However, any projections of cash flow are subject to
uncertainties, including those related to the Companys rate of revenue growth, its expansion of
sales and marketing activities, the timing and extent of spending in support of product development
efforts, the timing and success of new product introductions, continuing market acceptance of the
Companys products, costs and risks associated with the integration of acquired businesses, and the
Companys ability to manage its growth. In addition, although not currently a party to any letter
of intent or binding agreement, the Company may also invest in or acquire complementary businesses,
services, or technologies, which could require that funding be obtained through additional equity
or debt financing. It is possible that additional financing for any of these purposes could be
required, and that additional funds may not be available on favorable terms or at all.
ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
The debt instruments of the Company do not expose the Company to material market risks relating to
changes in interest rates.
Excess funds of the Company are invested in short-term, interest-bearing, investment-grade
securities. The value of these securities is subject to interest rate risk and could decline in
value if interest rates rise. The effect of a hypothetical one hundred basis point decrease across
all interest rates related to the Companys investments would result in an annual decrease of
approximately $0.1 million in operating results, assuming no change in the amount of investments on
hand at September 30, 2006.
The primary objective of the Companys investing activity is to preserve principal while maximizing
income without significantly increasing risk. Cash is invested principally in U.S. marketable debt
securities from a diversified portfolio of institutions with strong credit ratings and in U.S.
government agency notes. By policy, the amount of credit exposure to any single institution is
limited. These investments generally are not collateralized and mature in less than one year. To
minimize the exposure to changes in interest rates, the Company schedules its investments to mature
in line with expected cash needs, thus reducing the potential of selling investments prior to their
maturity. The Company believes it has minimal exposure to interest rate risk.
ITEM 4. CONTROLS AND PROCEDURES
The Company maintains disclosure controls and procedures, as defined in Rules 13a-15(e) and
15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended, that are designed to
ensure that information required to be disclosed in the reports filed or submitted by the Company
under the Exchange Act is recorded, processed, summarized, and reported within the time periods
specified in the SECs rules and forms and that such information is accumulated and communicated to
management of the Company, including its Chief Executive Officer and Chief Financial Officer, as
appropriate, to allow timely decisions regarding required disclosure. Charles A. Jett, Jr., Chief
Executive Officer and President, and W. Randall Pittman, Chief Financial Officer and Treasurer,
conducted an evaluation of the effectiveness of the design and operation of the Companys
disclosure controls and procedures as of September 30, 2006 and, based on that evaluation, found
the Companys disclosure controls and procedures were effective in ensuring that information
required to be disclosed in the reports filed by the Company and submitted under the Exchange Act
is recorded, processed, summarized and reported as and when required, and that information required
to be disclosed is accumulated and communicated to them as appropriate to allow timely decisions
regarding timely disclosure. There have been no changes in the Companys internal controls over
financial reporting during the nine months ended September 30, 2006 that have materially affected,
or are reasonably likely to materially affect, the Companys internal control over financial
reporting.
20
PART II. OTHER INFORMATION
ITEM 1A. RISK FACTORS
In addition to the other information set forth in this report, careful consideration should be
given to the factors discussed in Part I, Item 1A.
Risk Factors in the Companys Annual Report on
Form 10-K for the year ended December 31, 2005, which could materially affect the Companys
business, financial condition, or future results. The risks described in the Companys Annual
Report on Form 10-K are not the only risks facing the Company. Additional risks and uncertainties
not currently known or that are currently deemed to be immaterial also may materially adversely
affect the Companys business, financial condition, and/or operating results.
ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
The Companys initial public offering of its common stock was effected through a Registration
Statement on Form S-1 which was declared effective on February 8, 2005. In the offering the
Company sold 5,750,000 shares of common stock for net proceeds of approximately $67.2 million. On
February 18, 2005 the Company used $4.0 million of the proceeds to repay borrowings under its
subordinated notes, and invested the remaining proceeds in short-term, investment grade securities
pending further use. Since that time and through September 30, 2006, the Company has used
approximately $9.9 million of the net proceeds for capital purchases, substantially all of which
have been equipment, and an additional $40.0 million of the net proceeds to acquire all of the
outstanding stock of Camtronics Medical Systems, Ltd. on November 1, 2005.
ITEM 6. EXHIBITS
|
|
|
Exhibit No. |
|
Description |
|
|
|
31.1*
|
|
Certification of Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) under
the Securities Exchange Act of 1934 |
|
|
|
31.2*
|
|
Certification of Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a)
under the Securities Exchange Act of 1934 |
|
|
|
32*
|
|
Certifications of the Chief Executive Officer and Chief Financial Officer pursuant to
18 U.S.C.
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 |
21
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934,
Emageon Inc. has duly caused this report to be signed on its behalf by the undersigned, thereunto
duly authorized November 9, 2006.
|
|
|
|
|
|
|
EMAGEON INC. |
|
|
|
|
|
|
|
By: |
|
/s/ Charles A. Jett, Jr. |
|
|
|
|
|
|
|
|
|
Charles A. Jett, Jr. |
|
|
|
|
Chairman, Chief Executive Officer, and President |
|
|
|
|
(Principal Executive Officer) |
|
|
|
|
|
|
|
By: |
|
/s/ W. Randall Pittman |
|
|
|
|
|
|
|
|
|
W. Randall Pittman |
|
|
|
|
Chief Financial Officer and Treasurer |
|
|
|
|
(Principal Financial and Accounting Officer) |
22